Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer

Figure 3

Overall survival stratified by IGF1R and IGFBP3 expression in cancer cells in patients with clinical stage II tumors. Prognosis of IGF1R-positive cancer was significantly poorer (p = 0.008) than that of IGF1R-negative cancer in the stage II group. Analysis of prognosis of patients with IGF1R-positive and IGFBP3-negative tumors shows a significant correlation with overall survival (p = 0.0009) in patients with stage II tumors.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us